Publications by Professor Simon Bailey - ePrints

Browsing publications by Professor Simon Bailey.

Newcastle Authors	Title	Year
Alex Hagan Professor Simon Bailey Dr Sarah Verity	Barriers to the use of Methylphenidate in Pediatric Neuro-oncology Services	2024
Professor Simon Bailey	Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare disease	2024
Professor Simon Bailey	Correction to: Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial (Cancers, (2022), 14, 2, (374), 10.3390/cancers14020374)	2024
Dr Claire Keeling Dr Jack Goddard Dr Ed Schwalbe Professor Simon Bailey Dr Debbie Hicks et al.	MDB-31. The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients.	2024
Dr Marion Mateos Dr Daniel Williamson Dr Marina Danilenko Dr Jack Goddard Dr Stephen Crosier et al.	MDB-64. Novel transcripts associate with survival in childhood medulloblastoma.	2024
Dr Florence Burté Magretta Adiamah Dr Fatma Scerif Dr Debbie Hicks Dr Ed Schwalbe et al.	Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups	2024
Dr Claire Keeling Dr Jack Goddard Dr Ed Schwalbe Professor Simon Bailey Dr Debbie Hicks et al.	The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients	2024
Professor Simon Bailey	The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial	2024
Dr Rebecca Hill Dr Gail Halliday Dr Dipayan Mitra Professor Simon Bailey	A Primary Spinal Nongerminomatous Germ Cell Tumor With Multiple Intracranial Metastases in a Toddler	2023
Professor Simon Bailey Dr Dipayan Mitra	Applying machine learning classifiers to automate quality assessment of paediatric dynamic susceptibility contrast (DSC-) MRI data	2023
Dr Jack Goddard Jemma Castle Emily Southworth Anya Fletcher Dr Stephen Crosier et al.	Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification	2023
Professor Simon Bailey Professor Steven Clifford	Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study	2023
Professor Simon Bailey	Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials	2023
Dr Daniel Williamson Dr Ed Schwalbe Professor Simon Bailey Professor Steven Clifford	Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development	2023
Dr Frederik van Delft Professor Simon Bailey Professor Roderick Skinner Dr Geoff Shenton Dr Peter Carey et al.	Unusual relapse of low hypodiploid acute lymphoblastic leukaemia in a family with Li-Fraumeni syndrome	2023
Alex Hagan Professor Simon Bailey Dr Sarah Verity	Barriers to the use of methylphenidate in paediatric neuro-oncology services	2022
Dr Marion Mateos Dr Nikhil Birdi Dr Anna Basu Dr Michael Wright Dr Srinivas Annavarapu et al.	Developmental delay and progressive seizures in 2-month-old child with diffuse MRI abnormalities	2022
Dr Paul Morgan Professor Simon Bailey Dr Dipayan Mitra	Dynamic susceptibility-contrast magnetic resonance imaging with contrast agent leakage correction aids in predicting grade in pediatric brain tumours: a multicenter study	2022
Dr Ricky Tirtakusuma Dr Katarzyna Szoltysek Professor Vasily Grinev Dr Sirintra Nakjang Dr Daniel Williamson et al.	Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia	2022
Professor Simon Bailey Professor Steven Clifford	How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?	2022
Dr Jack Goddard Jemma Castle Emily Southworth Anya Fletcher Dr Stephen Crosier et al.	MEDB-71. Molecular characterisation of Group 4 medulloblastoma improves risk-stratification and its biological understanding	2022
Dr Daniel Williamson Dr Ed Schwalbe Dr Debbie Hicks Dr Janet Lindsey Dr Stephen Crosier et al.	Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development	2022
Dr Dipayan Mitra Professor Simon Bailey	Metabolite selection for machine learning in childhood brain tumour classification	2022
Professor Simon Bailey	Pediatric high-grade gliomas and the WHO CNS Tumor Classification - Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates	2022
Dr Rebecca Hill Professor Steven Clifford Professor Simon Bailey	Relapsed medulloblastoma in pre-irradiated patients: Current practice for diagnostics and treatment	2022
Dr Marina Danilenko Dr Claire Keeling Dr Stephen Crosier Dr Martina Finetti Dr Daniel Williamson et al.	Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development	2022
Professor Simon Bailey Professor ELizabeth Molyneux	Towards zero percent treatment abandonment of patients with common and curable childhood cancer types in Blantyre, Malawi	2022
Professor Simon Bailey Professor Steven Clifford	Acceptance and commitment therapy for young brain tumour survivors: Study protocol for an acceptability and feasibility trial	2021
Dr Stephen Crosier Dr Debbie Hicks Dr Ed Schwalbe Dr Daniel Williamson Amanda Smith et al.	Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics	2021
Dr Dipayan Mitra Professor Simon Bailey	Classification of paediatric brain tumours by diffusion weighted imaging and machine learning	2021
Professor Simon Bailey	Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome	2021
Professor Simon Bailey Professor Steven Clifford Dr Dipayan Mitra	Combining multi-site magnetic resonance imaging with machine learning predicts survival in pediatric brain tumors	2021
Dr Ugo Offor Professor Simon Bailey	Improving the early detection and management of constipation in children and young people living with cancer in the North East of England.	2021
Dr Vickyanne Carruthers Dr Rebecca Hill Ian Coulter Christopher Cowie Dr Gail Halliday et al.	Perioperative corticosteroid use in paediatric neuro-oncology	2021
Dr Debbie Hicks Dr Reza Rafiee Dr Ed Schwalbe Dr Christopher Howell Dr Janet Lindsey et al.	The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes	2021
Dr Ed Schwalbe Dr Peter Carey Professor Stephen O'Brien Professor Anthony Moorman Emilio Barretta et al.	Challenges of starting treatment protocols for acute lymphoblastic leukaemia in a low-income setting — the Blantyre experience	2020
Dr Stephen Crosier Professor Simon Bailey	Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes	2020
Professor Simon Bailey	Outcome at the end of treatment of patients with common and curable childhood cancer types in Blantyre, Malawi	2020
Dr Yura Grabovska Dr Stephen Crosier Dr Martina Finetti Dr Ed Schwalbe Dr Rebecca Hill et al.	Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity	2020
Dr Rebecca Hill Dr Stacey Richardson Dr Ed Schwalbe Dr Debbie Hicks Dr Janet Lindsey et al.	Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study	2020
Dr Martina Finetti Yura Grabovska Professor Simon Bailey Dr Daniel Williamson	Translational Genomics of Malignant Rhabdoid Tumours: Current Impact and Future Possibilities	2020
Professor Simon Bailey	Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?	2019
Dr Marion Mateos Dr Nikhil Birdi Dr Vankateswara Ramesh Dr Anna Basu Dr Srinivas Annavarapu et al.	Neoplasia or Neonatal Alexander Disease?	2019
Dr Ed Schwalbe Dr Daniel Williamson Dr Janet Lindsey Dr Rebecca Hill Dr Debbie Hicks et al.	Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes	2019
Dr Peixun Zhou Dr Alex Blain Alex Newman Dr Masood Zaka Dr Ugo Offor et al.	Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif	2019
Professor Simon Bailey	The utility of routine surveillance screening with magnetic resonance imaging to detect tumor recurrence/progression in children with high-grade central nervous system tumors: a systematic review	2019
Dr Morven Brown Professor Simon Bailey	“They've got a lot of needs and I don't think they're being met fully”: A qualitative study of the multi‐professional team approach to the management of children with optic pathway gliomas	2018
Professor Simon Bailey	A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP)	2018
Dr Peixun Zhou Dr Amir Enshaei Alex Newman Dr Amy Erhorn Amy Barnard et al.	A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma	2018
Dr Peixun Zhou Dr Amir Enshaei Alex Newman Dr Amy Erhorn Amy Barnard et al.	A Genomic Classification Model Enables Risk Stratification of Paediatric Endemic Burkitt Lymphona in Malawi	2018
Dr Dipayan Mitra Professor Simon Bailey	Application of pattern recognition techniques for classification of pediatric brain tumors by in vivo 3T ¹H-MR spectroscopy - A multi-center study	2018
Professor Simon Bailey	Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries	2018
Dr Peixun Zhou Alex Newman Filbert Adlar Casey Broadbent Dr Alison Blain et al.	Investigation of FOXO1 mutations in paediatric endemic and sporadic Burkitt lymphoma	2018
Professor Simon Bailey Dr Pamela Kearns	The utility of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with low-grade central nervous system (CNS) tumours: a systematic review	2018
Professor Simon Bailey	Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children	2018
Professor Simon Bailey	Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease	2017
Dr Ed Schwalbe Dr Janet Lindsey Dr Sirintra Nakjang Dr Stephen Crosier Amanda Smith et al.	Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study	2017
Professor Simon Bailey	SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings	2017
Dr Ed Schwalbe Dr Kevin Windebank Professor Stephen O'Brien Dr Peter Carey Professor Simon Bailey et al.	The use of anthracyclines in the treatment of endemic Burkitt lymphoma	2017
Professor Simon Bailey	TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity	2017
Dr Morven Brown Professor Roderick Skinner Professor Simon Bailey	A School Passport as Part of a Protocol to Assist Educational Reintegration After Medulloblastoma Treatment in Childhood	2016
Dr Stephen Crosier Dr Debbie Hicks Dr Ed Schwalbe Dr Daniel Williamson Sarah Nicholson et al.	Centralised Molecular Pathology for Rare Tumours: A National Feasibility Study of Real-Time Medulloblastoma Diagnostics	2016
Faye Fraser Dr Morven Brown Professor Roderick Skinner Professor Simon Bailey	Developing A Model Of Reintegration Into Education Post-Medulloblastoma Treatment In Children: A Thematic Analysis	2016
Dr Dipayan Mitra Professor Simon Bailey	Development of clinical guidelines for the treatment of low grade gliomas in lower and lower middle income countries - a SIOP PODC initiative	2016
Professor Simon Bailey Dr Janet Lindsey Professor Steven Clifford	Divergent clonal selection dominates medulloblastoma at recurrence	2016
Dr Debbie Hicks Dr Ed Schwalbe Dr Stephen Crosier Professor Simon Bailey Dr Daniel Williamson et al.	Identification of medulloblastoma molecular subgroups using metabolite profiles	2016
Dr Richard McNally Professor Simon Bailey	Incidence and survival of children and young people with central nervous system embryonal tumours in the North of England, 1990-2013	2016
Dr Martina Finetti Matthew Selby Dr Matthew Bashton Dr Ruth Cranston Dr Stephen Crosier et al.	Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities	2016
Dr Martina Finetti Alicia Del Carpio Pons James Barker James Wood Dr Sirintra Nakjang et al.	Integrated pathway analysis of rhabdoid tumor subtypes identifies key SMARCB1-dependencies and therapeutic opportunities	2016
Professor Simon Bailey Dr James Hayden	Intensive treatment of high-risk medulloblastoma (HR-MB): How to learn from toxicities in an European setting of radiotherapists and physicists of the SIOP Brain Tumor Working Group	2016
Matthew Selby Dr Martina Finetti Dr Matthew Bashton Dr Ruth Cranston Alicia Del Carpio Pons et al.	Investigating the biology of atypical teratoid/rhabdoid tumors by whole genome CRISPR/CAS9 screening	2016
Dr Janet Lindsey Dr Rebecca Hill Dr Ed Schwalbe Dr Christopher Howell Dr Reza Rafiee et al.	Molecular and Prognostic Heterogeneity within MYC and MYCN Amplified Medulloblastomas	2016
Professor Simon Bailey Professor Steven Clifford	Risk stratification of childhood medulloblastoma in the molecular era: the current consensus	2016
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al.	Routine Diagnostic Medulloblastoma Subgrouping Using Low-Cost, Low-Input DNA Methylomics: Application to Trials Cohorts Previously Refractory-to-Analysis	2016
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Matthew Bashton Dr Amir Enshaei et al.	Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics	2016
Dr Debbie Hicks Dr Reza Rafiee Dr Ed Schwalbe Dr Christopher Howell Dr Janet Lindsey et al.	Subgroup-Directed Stratification of Risk in Infant Medulloblastoma	2016
Professor Simon Bailey	The impact of routine surveillance screening with magnetic resonance imaging (MRI) to detect tumour recurrence in children with central nervous system (CNS) tumours: Protocol for a systematic review and meta-analysis	2016
Dr Morven Brown Professor Mark Pearce Professor Simon Bailey Professor Roderick Skinner	The long-term psychosocial impact of cancer: the views of young adult survivors of childhood cancer	2016
Dr Daniel Williamson Dr Janet Lindsey Dr Debbie Hicks Dr Stephen Crosier Amanda Smith et al.	The Transcriptional Landscape of Medulloblastoma: Group 3 and Group 4 Tumours Comprise a Single Clinically Significant Expression Continuum	2016
Dr Rebecca Hill Dr Janet Lindsey Dr Ed Schwalbe Dr Karen Barker Dr Daniel Williamson et al.	Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease	2015
Dr Janet Lindsey Dr Ed Schwalbe Matthew Selby Dr James Hayden Dr Daniel Williamson et al.	Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance	2015
Dr Peixun Zhou Alex Newman Dr Amy Erhorn Dr Christopher Bacon Professor Simon Bailey et al.	Investigation of prognostic markers in endemic Burkitt lymphoma	2015
Dr Dipayan Mitra Professor Simon Bailey	SIOP PODC Adapted Treatment Recommendations for Standard-Risk Medulloblastoma in Low and Middle Income Settings	2015
Professor Simon Bailey Professor Roderick Skinner	The long-term psychosocial impact of cancer - the views of young adult survivors of childhood and adolescent cancer	2015
Dr Ed Schwalbe Dr Kevin Windebank Dr Peter Carey Professor Simon Bailey	The Role of Anthracyclines in the Treatment of Endemic Burkitt Lymphoma	2015
Dr Janet Lindsey Dr Ed Schwalbe Sandeep Potluri Professor Simon Bailey Dr Daniel Williamson et al.	TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours	2014
Dr Martina Finetti Alicia Del Carpio Pons Ben Skalkoyannis Matthew Selby Amanda Smith et al.	A Systems Biology Approach to Identify Mechanism of Tumourigenesis Caused by Loss of SMARCB1 in Malignant Rhabdoid Tumors (BACR28)	2014
Professor Simon Bailey Professor David Ellison Professor Steven Clifford	An Exploration of Associations between Health Related Quality of Life and Medulloblastoma Molecular Subgroup Status in Survivors from the SIOP UKCCSG PNET3 Trial	2014
Dr Martina Finetti Matthew Selby Dr Stephen Crosier Ben Skalkoyannis Professor Simon Bailey et al.	Characterising critical pathways in ATRT tumourigenesis: a genome-wide analysis of primary tumours and functional genomic models	2014
Dr Janet Lindsey Dr Ed Schwalbe Dr James Hayden Professor David Ellison Dr Daniel Williamson et al.	Cross-Species Epigenetics Identifies a Critial Role for VAV1 in the Maintenance of Sonic Hedgehog Subgroup Medulloblastomas	2014
Professor Simon Bailey Dr Janet Lindsey Professor Steven Clifford	Cytogenetic Prognostication Within Medulloblastoma Subgroups	2014
Dr Nicholas Bown Dr Sujith Samarasinghe Professor Simon Bailey Professor Roderick Skinner	FLT3 internal tandem duplication and NPM1 mutations in paediatric AML: a single centre experience	2014
Dr Thomas Pope Professor Simon Bailey	Graphene Sculpturene Nanopores for DNA Nucleobase Sensing	2014
Professor Simon Bailey Professor David Ellison Professor Steven Clifford	Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors	2014
Professor Simon Bailey	Intracystic interferon therapy in childhood craniopharyngioma: Who, when and how?	2014
Professor Simon Bailey	Management of Children with Wilms Tumor in Africa and Europe; Thoughts About Costs, Priorities and Collaboration	2014
Dr Martina Finetti Ben Skalkoyannis Matthew Selby Dr Stephen Crosier Professor Simon Bailey et al.	Mechanism of tumourigenesis caused by loss of SMARCB1 in malignant rhabdoid tumors	2014
Professor Simon Bailey Professor Steven Clifford Dr Daniel Williamson	Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group	2014
Dr Rebecca Hill Dr Janet Lindsey Dr Ed Schwalbe Dr Daniel Williamson Dr Sarra Ryan et al.	MYC and TP53 defects emerge and interact at medulloblastoma relapse, define rapidly progressive disease and can be targeted therapeutically	2014
Dr Rebecca Hill Dr Janet Lindsey Dr Ed Schwalbe Dr Karen Barker Dr Daniel Williamson et al.	MYC and TP53 defects interact at medulloblastoma relapse to define rapidly progressive disease and can be targeted therapeutically	2014
Dr Martina Finetti Matthew Selby Alicia Del Carpio Pons Ben Skalkoyannis Amanda Smith et al.	Next-generation sequencing identifies the mechanism of tumourigenesis caused by loss of SMARCB1 in malignant rhabdoid tumours	2014
Dr Ed Schwalbe Dr Debbie Hicks Dr Reza Rafiee Dr Amir Enshaei Sandeep Potluri et al.	Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost DNA methylomics	2014
Professor Simon Bailey	Wilms Tumour in Malawi: Surgical Staging to Stratify Postoperative Chemotherapy?	2014
Professor Simon Bailey	Wilms Tumour in Malawi: Surgical Staging to Stratify Postoperative Chemotherapy?	2014
Dr Ed Schwalbe Dr Daniel Williamson Dr Janet Lindsey Dolores Hamilton Sarra Ryan et al.	DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies	2013
Dr Ed Schwalbe Dr James Hayden Dr Janet Lindsey Dr Rebecca Hill Sarah Nicholson et al.	Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types	2013
Dr Rebecca Hill Dr Janet Lindsey Dr Ed Schwalbe Professor Simon Bailey Professor Steven Clifford et al.	Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma	2013
Dr Peter Carey Claire Schwab Dr Lucy Chilton Dr Ed Schwalbe Professor Roderick Skinner et al.	Treating childhood acute lymphoblastic leukemia in Malawi	2013
Dr Sarra Ryan Dr Ed Schwalbe Mike Cole Yuan Lu Dr Meryl Lusher et al.	MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma	2012
Professor Graham Jackson Professor Christine Harrison FRCPath FMedSci Professor Simon Bailey	Burkitt's lymphoma	2012
Dr Ed Schwalbe Dr Janet Lindsey Dr Daniel Williamson Kieran O'Toole Dr Meryl Lusher et al.	Epigenetic sub-classification and risk-stratification of medulloblastoma using DNA methylomics	2012
Sarah Wilkinson Amy Bradburn Professor Simon Bailey Dr Christopher Bacon Dr Vikki Rand et al.	High-resolution genome-wide analysis of endemic Burkitt Lymphoma using DNA extracted from fine-needle aspirates preserved at ambient temperature	2012
Dr Janet Lindsey Professor Simon Bailey Professor Steven Clifford	Subgroup-specific structural variation across 1,000 medulloblastoma genomes	2012
Dr Jonathan Fisher Lisa Price Dr Juliet Hale Professor Steven Clifford Professor Simon Bailey et al.	The importance of biopsy following radiological diagnosis of relapsed medulloblastoma	2012
Professor Simon Bailey Professor Roderick Skinner Dr Peter Carey Professor Anthony Moorman	Acute lymphoblastic leukarmia (ALL) in Malawi, progress in the first Malawi ALL protocol	2011
Professor David Ellison Dr Hisham Megahed Dr Meryl Lusher Dr Sarra Ryan Professor Simon Bailey et al.	Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables	2011
Professor David Ellison Sarah Nicholson Professor Simon Bailey Professor Steven Clifford Dr Richard Gilbertson et al.	Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups	2011
Dr Ed Schwalbe Dr Janet Lindsey Debbie Straughton Mike Cole Dr Hisham Megahed et al.	Rapid Diagnosis of Medulloblastoma Molecular Subgroups	2011
Dr Janet Lindsey Dr Rebecca Hill Dr Hisham Megahed Dr Meryl Lusher Dr Ed Schwalbe et al.	TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas	2011
Dr Akash Sinha Dr Peter Avery Professor Simon Bailey Professor Timothy Cheetham	Vitamin D Status in Paediatric Patients With Cancer	2011
Professor David Ellison Dr Hisham Megahed Dr Sarra Ryan Dr Meryl Lusher Sarah Nicholson et al.	Clinical, pathological, and molecular variables define risk-stratification groups in childhood medulloblastoma	2010
Dr Hisham Megahed Dr Sarra Ryan Dr Meryl Lusher Sarah Nicholson Professor Simon Bailey et al.	Clinical, Pathological, and Molecular Variables Define Risk-Stratification Groups in Childhood Medulloblastoma	2010
Dr Ed Schwalbe Dr Janet Lindsey Dr Meryl Lusher Kieran O'Toole Sarah Nicholson et al.	DNA methylomics identifies clinically significant epigenetic subgroups of medulloblastoma	2010
Dr James Hayden Dr Matthew Allen Dr Sarra Ryan Sarah Nicholson Dr Ed Schwalbe et al.	Molecular Mechanisms in Supratentorial CNS-PNET development	2010
Dr Jun Ma Professor Simon Bailey Professor David Ellison	MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas	2010
Professor Steven Clifford Dr Sarra Ryan Mike Cole Dr Meryl Lusher Kieran O'Toole et al.	MYC gene family amplification and expression in childhood medulloblastoma: Biological significance and utility for high-risk disease stratification	2010
Sarina Sulong Professor Anthony Moorman Professor Julie Irving Marian Case Professor Simon Bailey et al.	A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups	2009
Professor Simon Bailey	Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.	2009
Professor David Ellison Professor Simon Bailey	Activation of the MAPK Pathway: A Signature Genetic Defect in Posterior Fossa Pilocytic Astrocytomas	2009
Dr Sarra Ryan Professor David Elliott Professor David Ellison Professor Simon Bailey Professor Steven Clifford et al.	Amplification and overexpression of Hsa-miR-3ob, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma	2009
Kate Wilson Marian Case Lynne Minto Professor Simon Bailey Dr Nicholas Bown et al.	Flow minimal residue disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34⁺CD38^lowCD19⁺ in B-lineage childhoood acute lymphoblastic leukemia	2009
Dr James Hayden Professor David Ellison Professor Simon Bailey Professor Steven Clifford	Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children	2009
Professor Timothy Cheetham Professor Simon Bailey	Hypercalcemia in Acute Lymphoblastic Leukemia: An Overview.	2009
Professor Simon Bailey Professor Roderick Skinner	Paediatric Haematology and Oncology	2009
Dr James Hayden Dr David Saunders Professor Simon Bailey	Prolonged detection of viral DNA in blood following life-threatening chickenpox in an immunocompromised child	2009
Jennifer Anderton Dr Janet Lindsey Dr Meryl Lusher Dr Richard Gilbertson Professor Simon Bailey et al.	Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2	2008
Marian Case Elizabeth Matheson Lynne Minto Dr Nicholas Bown Professor Simon Bailey et al.	Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia	2008
Marian Case Elizabeth Matheson Lynne Minto Professor Christine Harrison FRCPath FMedSci Dr Nicholas Bown et al.	Somatic mutation of genes impacting on the RAS-RAF-MEK-ERK pathway is the most common genetic abnormality in childhood acute lymphoblastic leukaemia, is implicated in disease progression and provides a rationale for therapeutic targeting	2008
Kerrie Wilson Marian Case Lynne Minto Professor Simon Bailey Professor Hermann Josef Vormoor et al.	The CD34⁺ CD38^Low CD19⁺ Candidate Leukemic Stem Cell Phenotype Revisited: Useful for Flow MRD Monitoring?	2008
Dr Andrew Hall Sarina Sulong Professor Christine Harrison FRCPath FMedSci Lynne Minto Dr Nicholas Bown et al.	Assessment of aneuploidy in childhood acute lymphoblastic leukaemia using high density oligonucleotide arrays.	2006
Professor Simon Bailey	Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells	2006
Sarina Sulong Professor Julie Irving Marian Case Lynne Minto Dr Nicholas Bown et al.	Comprehensive analysis of p16(INK4a) in childhood acute lymphoblastic leukemia reveals homozygous deletion, haploinsufficiency and acquired isodisomy at the 9p locus with intact p16(INK4a).	2006
Dr Janet Lindsey Dr Meryl Lusher Dr Gordon Strathdee Robert Brown Dr Richard Gilbertson et al.	Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours	2006
Dr Janet Lindsey Dr Meryl Lusher Dr Gordon Strathdee Dr Richard Gilbertson Professor Simon Bailey et al.	Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours	2006
Dr Poonam Dharmaraj Dr Stephen Ball Dr HC Johnstone Professor Simon Bailey Professor Steven Clifford et al.	Hypercalcaemia in relapsed medulloblastoma 8 years post-diagnosis; evidence to support PTHrP production by medulloblastoma cells	2006
Dr Debbie Scott Debbie Straughton Mike Cole Professor Simon Bailey Professor David Ellison et al.	Identification and analysis of tumor suppressor loci at chromosome 10q23.3-10q25.3 in medulloblastoma	2006
Professor Julie Irving Lynne Minto Elizabeth Matheson Marian Case Professor Simon Bailey et al.	Mutation in genes impacting on the RAS-RAF-MEK-ERK pathway are found at high incidence in childhood acute lymphoblastic leukemia at both diagnosis and at relapse.	2006
Professor Julie Irving Lynne Minto Professor Simon Bailey Dr Andrew Hall	Loss of heterozygosity and somatic mutations of the Glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course	2005
Dr Janet Lindsey Dr Meryl Lusher Jennifer Anderton Professor Simon Bailey Dr Richard Gilbertson et al.	Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling	2004
Professor Simon Bailey Dr Andrew Hall Professor Andrew Pearson Dr Chris Redfern	The role of AP-1 in glucocorticoid resistance in leukaemia	2001
Professor Simon Bailey	The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity	2000
Professor Simon Bailey Dr Andrew Hall Professor Andrew Pearson Dr Michael Reid Dr Chris Redfern et al.	Glucocorticoid resistance and the AP-1 transcription factor in leukaemia	1999
Professor Simon Bailey	Acute Lymphoblastic Leukaemia, The Wellington Experience 1980-1992	1996
Professor Simon Bailey Professor Roderick Skinner Dr Helen Lucraft Emeritus Professor Robert Perry Nicholas Todd et al.	Pineal tumours in the north of England 1968-93	1996